BeOne Medicines has secured approval from the EC for Tevimbra (tislelizumab) to ...
The FDA has issued more than 200 complete response letters, which detail reasons...
With clinical trials under pressure, industry leaders say it’s time for reform, ...
IGI Therapeutics has signed an exclusive licensing agreement with AbbVie, for IS...
Transcend Therapeutics announced that the FDA has granted breakthrough therapy d...
Achieving good oral bioavailability for targeted protein degraders (TPDs) is vit...
The US dominates overall sales, yet GlobalData predicts that China is shaping up...
Amid new regulations, changes in tariffs, supply chain disruptions, we look at h...
Zentiva Group has entered a licence and supply agreement with Lupin for the comm...
Merck has entered a definitive agreement to acquire biopharmaceutical company Ve...
In a recent webinar, industry experts explain how real-world data and patient-ce...
A panel at CTO East Coast discussed the regulatory changes impacting oncology tr...
Global funding cuts, including those made by the Trump administration, are set t...
Swissmedic approved the registration of IFINWIL (eflornithine) as a monotherapy ...
Chugai signed a joint research and licencing agreement with Singapore-based biot...
